CervoMed
Price & Volume
Stats
See more52W Range | $2.13-$11.25 |
Market Cap | $33M |
Shares Short | 807,562 |
Financials
See moreRevenue (12 Mos) | $2M |
Revenue Growth (YoY) | -99.6% |
Gross Profit (12 Mos) | -$20M |
Diluted EPS | -$3.28 |
News
See moreYahoo Finance • 4 days ago
CervoMed Completes Enrollment In Phase 2a Study Of Neflamapimod For Nfv.Primary Progressive Aphasia
Yahoo Finance • 5 days ago
CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia
Yahoo Finance • 8 days ago
CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026
Yahoo Finance • 22 days ago
Pre-Market Movers: TNON, ADTX, LNAI See Sharp Moves
About
CEO | Dr. John J. Alam M.D. |
CFO | Mr. William Robert Elder J.D. |
Address | 20 Park Plaza, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |